Clinical Trial Update: Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of Topiramate for weight loss in subjects with metabolic syndrome has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Northeastern Ohio Universities College of Medicine | Conditions: Metabolic Syndrome X, Diabetes Mellitus, Type 2 | Phase 3 | Status: SUSPENDED